Introduction
Pancreatic cancer is the fourth most common cause of cancer-related deaths in the
United States [1]
[2]. The prognosis for patients with pancreatic cancer is extremely poor, with the vast
majority of them dying within 1 year after receiving this diagnosis [1]
[3]
[4]. Patients undergo a number of diagnostic procedures to determine the presence of
pancreatic cancer, and typically, the primary care physician or oncologist is tasked
to deliver the results. However, endoscopic ultrasound-guided fine-needle aspiration
(EUS-FNA) has now become the standard of care for sampling pancreatic mass lesions
[5], which has increased the likelihood that endosonographers will be the first to make
the diagnosis. In addition, with the greater utilization of on-site cytopathology,
preliminary FNA results are usually available at the time of the procedure, when patients
and their families are still present. Therefore, endosonographers are now often faced
with the decision of whether to be the first health care providers to disclose a pancreatic
cancer diagnosis.
This paradigm shift in the diagnosis of pancreatic cancer has highlighted a major
training gap among interventional gastroenterologists – effective physician communication
about cancer and its prognosis. Strong physician communication skills have been linked
to higher levels of patient satisfaction, better outcomes, greater adherence to therapies,
reduced patient anxiety [6]
[7]
[8], and even increased cancer survival rates [9]
[10]. Furthermore, studies have shown that significant levels of physician stress and
burnout are related, among other factors, to inadequate training and uncertainty regarding
how to convey difficult news [11]
[12].
Effective communication in the setting of oncology has been stratified into three
skills: (i) delivery of the diagnosis and proper medical information, (ii) provision
of emotional support, and (iii) discussion and support of palliative care [13]. Although the third component may be less relevant for endosonographers, being prepared
to disclose a pancreatic cancer diagnosis and to support the patient emotionally is
a realistic expectation. The requirement for such skills poses a difficult clinical
challenge for gastroenterologists who have not been adequately trained to address
these issues with patients and/or cope with their own emotional reactions in this
role.
Oncologists communicate a new cancer diagnosis on average 35 times per month, essentially
on a daily basis [14]. Therefore, communication skills training is a formal component of hematology/oncology
fellowship training, incorporating cognitive, affective, and behavioral components
with the goal of promoting greater self-awareness [15]. Communication skills must be acquired during both clinical experience and formalized training [15]. Formal communication skills training is a part of most medical school curricula
through didactics and small-group role playing but is not required during medical
residencies or fellowships. The recently updated 2014 Accreditation Council for Graduate
Medical Education (ACGME) guidelines (http://www.acgme.org/acgmeweb/Portals/0/PDFs/Milestones/InternalMedicineMilestones.pdf) now emphasize the importance of training internal medicine residents in communication
skills, but not specifically in disclosing diagnoses. Furthermore, communication skills
training is not currently a requirement for gastroenterology training, despite the
increasing need to discuss new cancer diagnoses with our patients. Whether the responsibility
to disclose a diagnosis should fall to the endosonographer or the oncologist is unclear.
Regardless, it is important that endosonographers who do choose to initiate the cancer
discussion exhibit optimal communication skills, both for their patients’ and for
their own personal well-being.
Extensive literature is available on the efficacy of EUS for the diagnosis and staging
of pancreatic cancer, but no data are available on how best to communicate this information
to the patient or family. Furthermore, although coping styles among gastroenterologists
have been studied [16], no studies to date have specifically focused on how endosonographers cope with
the increasing demand of being the first health care providers to convey the diagnosis
of pancreatic cancer to a patient.
The aim of this study was to elucidate the current practice patterns, comfort levels,
and coping styles of academic and community endosonographers in the context of disclosing
a pancreatic cancer diagnosis. We hypothesized that given the lack of formalized training,
most endosonographers would hold reservations about disclosing a pancreatic cancer
diagnosis after an EUS examination, and that the highest levels of discomfort around
disclosure might be influenced by clinical experience and coping style.
Methods
Survey design
This study used a prospective, cross-sectional survey design. Via e-mail, we solicited
707 American Society of Gastrointestinal Endoscopy (ASGE) members from an existing
U.S. database of endosonographers to participate. The study was approved by the institutional
review board at Northwestern University. The database represents nearly all academic
institutions performing EUS and also a large number of community-based endosonographers.
Participants completed an online survey ([Fig. 1]) anonymously that included questions about basic demographics, practice data, and
factors that might influence the decision to disclose a diagnosis of pancreatic cancer,
including coping style.
Fig. 1 Survey of endosonographers’ practices and coping strategies for disclosing a pancreatic
cancer diagnosis.
Demographic and practice data
Participants were asked to provide information regarding their gender, primary practice
setting, years out of training, 4th-year advanced endoscopy training, and number of
EUS procedures performed annually, and about the availability of an on-site cytopathologist.
Disclosure of diagnosis
The second tier of questions assessed the endosonographers’ approach to and comfort
level around delivering a diagnosis of gastrointestinal cancer. Respondents were asked
to rate the following on a 5-point Likert scale: (i) comfort level when disclosing
a pancreatic cancer diagnosis vs. another gastrointestinal malignancy; (ii) preference
regarding having another physician (e. g., oncologist) deliver the diagnosis; and
(iii) perception of the adequacy of their training and reasons for lack of comfort
in delivering a cancer diagnosis. Participants were then asked to provide information
on the manner in which they disclosed a diagnosis of pancreatic cancer and the amount
of time they spent discussing prognosis, available support services, and treatment
options. Finally, the respondents were asked if the disclosure of a pancreatic cancer
diagnosis was an obligation of the endosonographer and whether they would participate
in communication skills training if it were offered to them. Although the respondents
were queried about the availability of on-site cytopathology and their comfort with
discussing a preliminary diagnosis, the current survey was not designed to compare
comfort levels at the disclosure of a preliminary diagnosis with those at the delivery
of a final diagnosis.
Physician coping styles
We subsequently invited the physicians participating in the study to complete a second
series of questions assessing their coping mechanisms while disclosing a pancreatic
cancer diagnosis. We administered the Brief COPE [17], a 28-item, validated self-report measure examining the frequency of use of common
coping strategies. The instructions were adjusted to inquire about coping in the context
of “giving difficult or bad news to patients.” Response options (on a 4-point Likert
scale) ranged from “I haven’t been doing this at all” to “I’ve been doing this a lot.”
A total of 14 unique coping strategies were identified falling into two subcategories – emotion-focused
and problem-focused coping. Coping strategies were considered “regularly used” when
a score of 3 or higher was met. Composite scores for emotion-focused coping and problem-focused
coping were calculated by summing the scores for the various items that corresponded
to the coping style.
Data analysis
Data were collected through Adobe FormsCentral survey software (Adobe Systems, San
Jose, California, USA) and transferred to IBM SPSS Statistics20 (IBM, Armonk, New
York, USA) for analysis. Descriptive data were reported as means, frequencies, and
percentages. Independent sample t tests and chi-squared tests were used for between-group comparisons.
Results
Study sample
For this survey, we contacted 707 ASGE members in an existing national database of
endosonographers, 162 of whom participated. The 10 physicians who initiated the survey
but did not complete it were excluded from the final analysis, resulting in a total
sample size of 152 (22 % response rate).
The physician demographic and practice data are summarized in [Table 1]. The majority of our respondents were male (86.2 %). Of those surveyed, 62 % had
completed advanced fellowship training in EUS, with a mean of 10.6 ± 8.5 years in
practice (62 % > 5 years and 38 % < 5 years). The sample was split equally between
community (47 %) and academic (53 %) endosonographers. Finally, 69 % of the respondents
performed more than 200 EUS procedures annually, and 90 % had on-site cytology available
to them.
Table 1
Baseline characteristics of endosonographers participating in a study of their approaches
to delivering a diagnosis of pancreatic cancer (N = 152).
Characteristic
|
Value
|
Demographics
|
|
Male, n (%)
|
131 (86.2)
|
4th-year training, n (%)
|
94 (61.8)
|
Years since completion of training, mean (SD)
|
10.6 (8.5)
|
Practice setting, n (%)
|
|
Academic
|
80 (53)
|
Private practice
|
72 (47)
|
Annual volume of EUS procedures, n (%)
|
|
50 – 100
|
10 (7)
|
100 – 200
|
36 (24)
|
200 – 400
|
64 (42)
|
> 400
|
42 (27)
|
On-site assessment available, n (%)
|
137 (90)
|
SD, standard deviation; EUS, endoscopic ultrasound.
Disclosure of a pancreatic cancer diagnosis
Nearly all (92 %) respondents felt an obligation to share a cancer diagnosis when
it was available to them; however, only 55 % felt that an “adequate” on-site assessment
was sufficient for them to do so. Nonetheless, only 13 % of those surveyed actually
referred the patient to another physician for disclosure of the diagnosis. Comfort
levels were significantly higher in those who performed more than 400 EUS procedures
annually (P < 0.05); performing 200 EUS procedures annually was sufficient among endosonographers
in academic settings (75 % vs. 63 %, P = 0.044; [Table 2]) and among endosonographers who had been in practice for longer than 5 years (P = 0.044). No other factors related to disclosure differed significantly by practice
type (academic or community) or by years in practice (< 5 or > 5), including the availability
of on-site cytopathology ( [Table 2]).
Table 2
Comparison of endosonographers in academic and private practice with respect to comfort
level in disclosing a pancreatic cancer diagnosis.
|
Community
|
Academic
|
P value
|
Respondents, %
|
47
|
53
|
0.19
|
> 200 EUS procedures per year, %
|
63
|
75
|
0.044
|
4th-year training, %
|
26
|
36
|
0.19
|
Availability of on-site cytopathology, %
|
90
|
90
|
0.54
|
Feeling obligated to disclose diagnosis, %
|
93
|
92
|
0.74
|
Feeling adequately trained to disclose diagnosis, %
|
35
|
35
|
0.11
|
EUS, endoscopic ultrasound.
While most of the endosonographers felt obliged to provide the diagnosis of pancreatic
cancer, the majority (80 %) surveyed did not discuss the prognosis or offer information
on patient or family support, citing lack of time as the most common reason. Most
respondents (85 %) spent less than 20 minutes disclosing a new pancreatic cancer diagnosis,
with 25 % allotting 10 minutes or less. The most common reasons endosonographers felt
uncomfortable disclosing a diagnosis were the following: (i) lack of adequate time
to discuss (46 %); anticipation of an unpleasant reaction from the patient or family
(33 %); the idea that pancreatic cancer is a death sentence (27 %); confusion regarding
how much information to disclose (22 %); and lack of adequate training (16 %) ([Table 3]). Although the majority of endosonographers felt obligated to disclose a diagnosis,
only 45 % felt they were adequately trained to do so.
Table 3
Reasons offered for discomfort in disclosing a pancreatic cancer diagnosis (N = 98).
Reason[*]
|
n (%)
|
Lack of time to deliver or discuss news
|
45 (46)
|
Anticipation of unpleasant reaction
|
32 (33)
|
Thinking that pancreatic cancer is a death sentence
|
26 (27)
|
Confusion about how much information to disclose
|
22 (22)
|
Feeling inadequately trained
|
16 (16)
|
Worry that family will become too attached
|
3 (3)
|
Thinking that I am just a technician
|
3 (3)
|
Other
|
13 (13)
|
* Respondents could choose more than one reason.
Communication skills training
None of the endosonographers surveyed had formal communication skills training during
their residency or fellowship. When questioned as to the optimal time for this training,
92 (61 %) felt that this should be offered during residency or fellowship training
to provide the greatest impact. Despite the lack of comfort with current training,
only 15 % of all the endosonographers surveyed were willing to participate in communication
skills training if it were offered to them now.
Physician coping
Of the 152 physicians participating in the first survey, 98 (64.5 %) agreed to complete
the Brief COPE questionnaire. The sample was split between community (43 %) and academic
medical settings (57 %). Of the participants, 86.2 % were male, and among those surveyed,
61.8 % had completed a 4th-year advanced endoscopy fellowship, with a mean of 11.2
± 8.5 years in practice. Of the sample, 69 % had completed more than 200 EUS procedures
annually, and 90 % had on-site cytology assessment available. As in the primary survey,
the vast majority of the respondents felt an obligation to share a cancer diagnosis
when it was available to them; 90 % reported that they felt comfortable or very comfortable
in adopting that role, and 83 % endorsed being the first to deliver such news.
Physicians who reported experiencing significant distress around disclosing a diagnosis
of cancer cited their concerns as being driven by the anticipation of an unpleasant
reaction from the patient (33 %) and/or their personal perception that pancreatic
cancer is “a death sentence” (27 %). In the sample, 46 % indicated that their distress
was related to not having enough time to speak with the patient regarding diagnosis
or treatment, and 22 % indicated that distress was related to confusion over what
kind of information to convey.
The respondents used a mixture of emotion-focused and problem-focused coping strategies.
The most commonly used coping strategies were the following: acceptance (68 %); positive
reframing, or trying to see things in a positive light (44 %); seeking social support – emotional
(32 %); active coping, or taking action to circumvent a stressor (31 %); self-distraction
(31 %); and religion (20 %). Endosonographers reported using least frequently the
strategies of denial, self-blame, and substance abuse ( [Table 4]).
Table 4
Coping strategies used by endosonographers when disclosing a pancreatic cancer diagnosis
(N = 98).
Strategy
|
Percentage, %
|
Problem-focused coping
|
|
Acceptance
|
68.4
|
Positive reframing
|
43.9
|
Seeking social support – emotional
|
31.6
|
Active coping
|
30.6
|
Planning
|
24.5
|
Seeking social support – instrumental
|
14.3
|
Emotion-focused coping
|
|
Self-distraction
|
30.6
|
Religion
|
20.4
|
Venting
|
18.4
|
Humor
|
14.3
|
Behavioral disengagement
|
4.1
|
Self-blame
|
4.1
|
Substance use
|
2.0
|
Denial
|
|
2.9
|
When between-group differences were examined, those in community settings were more
likely than those in academic settings to engage in venting (P = 0.02). Physicians with fewer than 5 years of experience were more likely to seek
instrumental support, such as advice from peers (P = 0.01), or to engage in venting (P = 0.02) than were more experienced physicians. Perhaps most striking, physicians
who anticipated an unpleasant reaction when disclosing a diagnosis were also more
like to engage in self-blame (P = 0.001). Between-group differences are displayed in [Table 5].
Table 5
Between-group comparisons of coping strategies among endosonographers (N = 98).
|
Chi-squared test
|
P value
|
Primary practice setting × coping strategy
|
|
|
Venting
|
χ2(2) = 8.3
|
0.016
|
> 400 EUS procedures performed annually × coping strategy
|
|
|
Distraction
|
χ2(1) = 3.9
|
0.05
|
Venting
|
χ2(2) = 5.9
|
0.05
|
Years in practice × coping strategy
|
|
|
Instrumental support
|
χ2(1) = 6.2
|
0.01
|
Venting
|
χ2(2) = 7.8
|
0.02
|
EUS, endoscopic ultrasound.
Discussion
Physician communication is an important and often overlooked component of patient
satisfaction and effective clinical care. Communication skills training is even more
essential when a cancer diagnosis is being disclosed. To our knowledge, there are
no formal requirements for communication skills training for gastroenterologists.
The widespread utilization of EUS for the diagnosis and staging of pancreatic cancer
has shifted the expectation of patients for disclosure of diagnosis toward gastroenterologists.
We report the results of a survey of U.S. endosonographers with respect to their practices
and level of comfort in disclosing a pancreatic cancer diagnosis. Although nearly
all endosonographers felt obligated to disclose a new diagnosis of pancreatic cancer
after EUS-FNA, very few felt adequately trained to perform this task effectively.
This lack of experience also influenced the respondents’ personal coping.
Communication skills training is an effective component of the oncology fellowship. Multiple
studies have validated the impact of communication skills training on patient satisfaction
[13]
[14]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]. The majority of structured communication skills training occurs in medical school,
where application to patients is generally conducted as simulation or role playing.
Although the ACGME has started to recognize the importance of communication skills
for resident physicians, formal requirements are still not in place. The focus of
training in gastroenterology has been on mastering medical knowledge and procedural
skill sets so that physicians will function successfully in practice (e. g., endoscopy),
and very little emphasis is placed on the comprehensive biopsychosocial model, which
can significantly reduce patient anxiety, improve clinical outcomes, and empower the
provider [9]
[26].
To date, no studies have assessed communication skills or communication skills training
in gastroenterology. This has become even more apparent with the emergence of EUS
as a final diagnostic modality for patients suspected to have pancreatic malignancy.
Our study highlights the importance and expectations of endosonographers in the disclosure
of a pancreatic cancer diagnosis. However, the importance of communication skills
training can be extrapolated to all gastroenterologists who face difficult discussions
with patients who have colon cancer, irritable bowel syndrome, or inflammatory bowel
disease.
One of the challenges of disclosing a diagnosis when EUS-FNA is performed is the availability
of a final diagnosis. The role of the on-site cytopathologist is to assess specimen
adequacy, not to provide an on-site diagnosis per se. However, in practice, we know
from experience that an “adequate” on-site assessment is generally always predictive
of a diagnosis of malignancy. In theory, if the endosonographer is to disclose the
diagnosis, he or she should wait until a final diagnosis is issued. This situation
remains unclear as only 53 % of the endosonographers surveyed felt comfortable in
disclosing a diagnosis based solely on on-site assessment, which may be indicative
of avoidance and discomfort in breaking the news.
In addition, understanding how physicians cope with conveying difficult news, particularly
a diagnosis with such high mortality rates, is important and often neglected. The
current study also highlights that those surveyed were likely to use a variety of
problem-focused and emotion-focused coping strategies when detecting and delivering
the diagnosis of pancreatic cancer. Previous studies have shown that problem-focused
strategies, such as active coping, planning, seeking out emotional and instrumental
support, acceptance, and positive reframing, are associated with a decrease in psychological
distress. In our study, the physicians with more experience and those with a high
volume of patients appeared to use these adaptive strategies more frequently, indicating
they were less likely than less experienced physicians to suffer psychological distress
as a result of their work. Less experienced physicians, and those with a lower volume
of cases, were less likely to use problem-focused strategies and more likely to engage
in less productive strategies, such as distraction and venting. It is possible that
as physicians become more experienced, they become better able to cope with the complexity
of the situation. Furthermore, more recently trained physicians who have focused primarily
on procedural training may be more prone to the negative impacts of stress. Those
who anticipated a bad reaction from a patient or felt that they did not have enough
time to speak with a patient engaged in the least helpful coping strategies, and these
concerns may be alleviated with training or simulation experiences. Indeed, the majority
of respondents indicated that training would be most impactful during residency and
fellowship.
The current survey study highlights the lack of communication skills training in physicians
currently providing a new pancreatic cancer diagnosis after EUS-FNA. There appears
to be some increase in comfort with a high volume of cases and longer years of experience.
Although there may be technical differences between academic and community endosonographers,
it appears that both groups are equally uncomfortable with their ability to disclose
a new diagnosis of pancreatic cancer.
This study has some limitations. There are inherent biases introduced with surveys
and from the utilization of a set database of endosonographers. The 22 % response
rate is good for a survey study but may still not be truly representative of all physicians
performing EUS, particularly those who are most uncomfortable about the topic. Secondly,
analysis of disclosure based on preliminary specimen adequacy vs. final diagnosis
was not assessed and could be affected by the rigidity of cytopathology disclosure
of the diagnosis on site. In addition, it is possible that endosonographers would
not disclose a diagnosis until completion of the staging work-up so as to better assess
disease prognosis. Finally, the current study was limited to U.S. endosonographers
and does not represent the global endosonography community. The strength of this study
includes the overall response rate and a balanced participation from academic, community,
experienced, and novice endosonographers.
In summary, comfort levels in disclosing a pancreatic cancer diagnosis after performing
EUS appear to be higher for endosonographers with a greater volume of cases and more
experience but are not influenced by practice setting. Furthermore, experienced endosonographers
used more effective coping strategies; however, with practice patterns rapidly shifting
toward endosonographers being the first to disclose a diagnosis, experience may not
be enough to reduce provider distress. While the majority of endosonographers feel
obligated to disclose a pancreatic cancer diagnosis after EUS, the lack of time and
proper training, particularly among more junior providers, limits their comfort with
disclosure and results in negative coping styles. Formal communication skills training
within gastroenterology fellowships should be considered.